Emeryville, CA, United States of America

Babak Sanii

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Nutcracker Therapeutics, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Babak Sanii. Retrieved from https://idiyas.com/inventor/babak-sanii-rjeveece

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Babak Sanii: Innovator in Microfluidic Technology

Introduction

Babak Sanii is a prominent inventor based in Emeryville, CA (US). He has made significant contributions to the field of biotechnology, particularly in the development of microfluidic technologies. His innovative work focuses on enhancing the detection and measurement of DNA and RNA production.

Latest Patents

Babak Sanii holds a patent for "Apparatuses and methods for measuring DNA/RNA production in biochips." This invention involves microfluidic apparatuses and methods that provide detection of polynucleotide concentration. The apparatuses may include removable, single-use, or reusable microfluidic members that consist of channels, chambers, and substrates for performing microfluidic maneuvers. These devices are specifically designed for the detection of polynucleotide concentration, enhancing the efficiency of genetic analysis.

Career Highlights

Babak Sanii is currently associated with Nutcracker Therapeutics, Inc., where he continues to innovate in the field of biotechnology. His work at the company focuses on developing advanced solutions for genetic testing and analysis, contributing to the broader field of personalized medicine.

Collaborations

Due to space constraints, the collaborations section will be omitted.

Conclusion

Babak Sanii's contributions to microfluidic technology and genetic analysis are noteworthy. His patent and ongoing work at Nutcracker Therapeutics, Inc. highlight his role as a key innovator in the biotechnology sector.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…